INFANTILE HEMANGIOMA IN THE GLUTEAL REGION
Downloads
This case report describes the management of an infantile hemangioma (IH) in a 5-year-old child, diagnosed prenatally as an amorphous mass located in the right gluteal region. Over the child’s first five years, the vascular lesion progressively infiltrated adjacent soft tissues, compromising the functionality of the affected area. Despite initial treatment with propranolol, the patient showed a limited response, with lesion progression and associated symptoms. Due to the therapeutic ineffectiveness of the medication, surgical resection was chosen as the primary approach. The macrocystic lesion, with multiple loculations measuring approximately 10x4x7 cm, was removed without adverse complications. This case underscores the importance of early diagnosis and appropriate management of infantile hemangiomas, highlighting the surgical approach over the first-line treatment with propranolol in cases where initial treatment does not yield satisfactory results, especially in situations posing functional risks. The patient’s favorable outcome adds to the existing literature on the therapeutic outcomes of this approach.
Downloads
1. Tiemann, L., & Hein, S. (2020). Infantile hemangioma: A review of current pharmacotherapy treatment and practice pearls. Journal of Pediatric Pharmacology and Therapeutics, 25(7), 586-599. https://doi.org/10.5863/1551-6776-25.7.586
2. Couto, R. A., et al. (2012). Infantile hemangioma: Clinical evaluation of the involutive phase and implications for treatment. Plastic and Reconstructive Surgery, 130 (3), 619–624. https://doi.org/10.1097/PRS.0b013e31825dc129
3. Bauland, C. G., et al. (2011). Untreated hemangiomas: Growth pattern and residual lesions. Plastic and Reconstructive Surgery, 127(4), 1643–1648. https://doi.org/10.1097/PRS.0b013e318208d2ac
4. Wassef, M., et al. (2015). Classification of vascular anomalies: Recommendations from the International Society for the Study of Vascular Anomalies. Pediatrics, 13(1), 203–214. https://doi.org/10.1542/peds.2014-3673
5. Suh, K. Y., & Frieden, I. J. (2010). Infantile hemangiomas with minimal or arrested growth: A retrospective case series. Archives of Dermatology, 146(9), 971–976. https://doi.org/10.1001/archdermatol.2010.197
6. Ma, E. H., et al. (2017). Infantile hemangioma with minimal or arrested growth: Further observations on clinical and histopathologic findings of this unique yet underrecognized entity. Pediatric Dermatology, 34(1), 64–71. https://doi.org/10.1111/pde.13022
7. North, P. E., et al. (2000). GLUT1: A newly discovered immunohistochemical marker for juvenile hemangiomas. Human Pathology, 31(1), 11–22. https://doi.org/10.1016/s0046-8177(00)80192-6
8. Huang, L., et al. (2015). Glucose transporter 1-positive endothelial cells in infantile hemangioma exhibit characteristics of facultative stem cells. Stem Cells, 33(1), 133–145. https://doi.org/10.1002/stem.1841
9. Haddad, G. V., Denevitz-Castro-Herdy, C., Barbosa, M. C. M., & Barbosa, A. D. M. (2021). Infantile hemangioma: 17 cases treated with propranolol. Revista de Pediatria SOPERJ, 21(4), 230–232. https://doi.org/10.31365/issn.2595-1769.v21i4p230-232
10. Aly, M. M., et al. (2015). Therapeutic superiority of propranolol combined with short-course steroids over propranolol monotherapy in infantile hemangioma. European Journal of Pediatrics, 174(11), 1503–1509. https://doi.org/10.1007/s00431-015-2561-1
11. Leaute-Labreze, C., et al. (2015). A randomized, controlled trial of oral propranolol in infantile hemangioma. New England Journal of Medicine, 372(8), 735–746. https://doi.org/10.1056/NEJMoa1404710
12. Pope, E. (2021). Commentary: Beta-blockers and sleep issues. Pediatric Dermatology, 38(2), 378–379. https://doi.org/10.1111/pde.14537
13. Bayart, C. B., et al. (2017). Atenolol versus propranolol for treatment of infantile hemangiomas during the proliferative phase: A retrospective noninferiority study. Pediatric Dermatology, 34(4), 413–421. https://doi.org/10.1111/pde.13177
14. Shah, S. D., et al. (2016). Rebound growth of infantile hemangiomas after propranolol therapy. Pediatrics, 137(4), e20151754. https://doi.org/10.1542/peds.2015-1754
15. Cheng, J., Liu, B., & Lee, H. J. (2019). Outcomes of surgical treatment for hemangiomas. Pediatric Dermatology, 36(2), 207–212. https://doi.org/10.1111/pde.13751
16. Brasil, Ministério da Saúde. Secretaria de Atenção à Saúde. Secretaria de Ciência, Tecnologia e Insumos Estratégicos. (2018). Joint Ordinance No. 6, of February 23, 2018. Brasília.
Copyright (c) 2025 Mary Sthelly Da Mata Costa Rodrigues, Maysa Alves Rodrigues Brandão Rangel
This work is licensed under a Creative Commons Attribution 4.0 International License.
